SNAP25 and Creutzfeldt Jacob disease: Notably, SNAP-25 maintained the high diagnostic power even for the rare and atypical sCJD subtypes (MV2K, MM2C, MM2T, and VV1) often showing low t-tau and 14–3-3 CSF levels [29], thus making it a valuable biomarker for the whole CJD spectrum.